Add to ORKGRifampicin is one of the major antibiotics used in the treatment of Mycobacterium tuberculosis. This organism causes tuberculosis. Other related nocardioform bacteria which include the Rhodococci are opportunistic pathogens in AIDS patients. These organisms cause tuberculosis-like disease and are currently treated with rifampicin and other drugs. The presence of a low level rifampicin resistance mechanism was identified in seven rhodococcal strains and five other related and unrelated bacteria. Abbreviated Abstract. Open document to view full version]GR201
Rifampicin is an effective antibiotic against mycobacterial and other bacterial infections, but resi...
Objectives: It has long been assumed that some rifampicin-resistant Mycobacterium tuberculosis strai...
Background: Rifampicin (RIF) plays a pivotal role in the treatment of tuberculosis due to its bacter...
A DNA clone from Rhodococcus equi conferring low-level rifampin resistance through the ability to in...
Control of tuberculosis is threatened by widespread emergence of drug resistance in Mycobacterium tu...
Tuberculosis or TB is an airborne disease caused by the non-motile bacilli, Mycobacterium tuberculos...
The molecular mechanisms of resistance to streptomycin, rifampin, and isoniazid in 53 Myco-bacterium...
Rifampin is a front-line antibiotic for the treatment of tuberculosis. Infections caused by rifampin...
The development of pathogens regarding drug-resistant impersonates high public health threat. Though...
International audienceThe first antibiotic of the ansamycin family, rifampicin (RIF), was isolated i...
Objectives: Ninety-six percent of rifampicin resistance in Mycobacterium tuberculosis was shown to b...
An accurate identification of different species of Mycobacterium provides to allow appropriate treat...
[[abstract]]Most rifampicin-resistant strains have been associated with mutations in an 81-bp rifamp...
A collection of 24 rifampin-resistant clinical isolates of Mycobacterium tuberculosis with character...
Objectives: Rifampicin, a potent first-line TB drug of the rifamycin group, shows only little activi...
Rifampicin is an effective antibiotic against mycobacterial and other bacterial infections, but resi...
Objectives: It has long been assumed that some rifampicin-resistant Mycobacterium tuberculosis strai...
Background: Rifampicin (RIF) plays a pivotal role in the treatment of tuberculosis due to its bacter...
A DNA clone from Rhodococcus equi conferring low-level rifampin resistance through the ability to in...
Control of tuberculosis is threatened by widespread emergence of drug resistance in Mycobacterium tu...
Tuberculosis or TB is an airborne disease caused by the non-motile bacilli, Mycobacterium tuberculos...
The molecular mechanisms of resistance to streptomycin, rifampin, and isoniazid in 53 Myco-bacterium...
Rifampin is a front-line antibiotic for the treatment of tuberculosis. Infections caused by rifampin...
The development of pathogens regarding drug-resistant impersonates high public health threat. Though...
International audienceThe first antibiotic of the ansamycin family, rifampicin (RIF), was isolated i...
Objectives: Ninety-six percent of rifampicin resistance in Mycobacterium tuberculosis was shown to b...
An accurate identification of different species of Mycobacterium provides to allow appropriate treat...
[[abstract]]Most rifampicin-resistant strains have been associated with mutations in an 81-bp rifamp...
A collection of 24 rifampin-resistant clinical isolates of Mycobacterium tuberculosis with character...
Objectives: Rifampicin, a potent first-line TB drug of the rifamycin group, shows only little activi...
Rifampicin is an effective antibiotic against mycobacterial and other bacterial infections, but resi...
Objectives: It has long been assumed that some rifampicin-resistant Mycobacterium tuberculosis strai...
Background: Rifampicin (RIF) plays a pivotal role in the treatment of tuberculosis due to its bacter...